Weijie Ma
Tianjin University(CN)Wuhan University(CN)China General Nuclear Power Corporation (China)(CN)Wuhan Prevention and Treatment Center for Occupational Diseases(CN)Wuhan Pulmonary Hospital(CN)Research Institute for Electromagnetic Materials(JP)Beijing National Laboratory for Molecular Sciences(CN)Zhongnan Hospital of Wuhan University(CN)Collaborative Innovation Center of Chemical Science and Engineering Tianjin(CN)Hubei University(CN)
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, RNA modifications and cancer, Cancer-related molecular mechanisms research, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma(2021)234 cited
- → METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression(2023)203 cited
- → Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma(2017)166 cited
- → Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer(2021)150 cited
- → Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis(2023)123 cited
- → Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors(2021)